Show simple item record

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

dc.contributor.authorSantonastaso, Massimo
dc.contributor.authorUresin, Yagiz
dc.contributor.authorSchpe, Diethelm
dc.contributor.authorIbram, Ghionul
dc.contributor.authorTang, Hui
dc.contributor.authorSatlin, Andrew
dc.contributor.authorTaylor, Addison A.
dc.contributor.authorKilo, Cbarles
dc.date.accessioned2021-03-05T15:27:24Z
dc.date.available2021-03-05T15:27:24Z
dc.date.issued2007
dc.identifier.citationUresin Y., Taylor A. A. , Kilo C., Schpe D., Santonastaso M., Ibram G., Tang H., Satlin A., "Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension", JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, cilt.8, ss.190-198, 2007
dc.identifier.issn1470-3203
dc.identifier.otherav_bc03e594-8983-4302-a737-c2eff3eff977
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/124980
dc.identifier.urihttps://doi.org/10.3317/jraas.2007.028
dc.description.abstractObjective. To assess the antihypertensive efficacy and safety of the combination of the direct renin inhibitor aliskiren and ramipril in patients with diabetes and hypertension.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleEfficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension
dc.typeMakale
dc.relation.journalJOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
dc.contributor.departmentNovartis , ,
dc.identifier.volume8
dc.identifier.issue4
dc.identifier.startpage190
dc.identifier.endpage198
dc.contributor.firstauthorID33235


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record